டெப்பி பரோன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from டெப்பி பரோன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In டெப்பி பரோன் Today - Breaking & Trending Today
Updated 2/17/2021 6:56 PM Despite a recommendation from district administrators to hire a firm to better address the needs of an increasingly diverse student population, the St. Charles Unit District 303 school board continues to debate the subject and hear from the community on both sides of the issue. At Tuesday s learning and teaching committee meeting, the board listened to a presentation from representatives of Deep Equity, a company that trains school staff on equity, diversity and inclusion. Deep Equity which also has worked with Batavia High School, Elgin Area School District U-46 and West Chicago Elementary School District 33 was chosen by district administrators over two other firms and would be paid $119,000 for its services. ....
Pfizer is investing US$25m in a US developer of live biotherapeutics, Vedanta Biosciences; that project is one of four investments, totaling US$120m, made by Pfizer in the second half of 2020 under its breakthrough growth program focused on clinical stage biotech companies of potential future strategic interest to the pharma giant. ....
These updates are republished press releases and communications from members of the Science|Business Network Pfizer invests $120M in four biotechnological innovation companies Pfizer Inc. today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI). Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to help ensure the continuity of promising clinical development programs of potential future strategic interest to Pfizer. Pfizer’s initial PBGI investments include: $10 million in Vancouver, BC-based ESSA Pharma (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. ....
First four investments of new program created to support clinical-stage biotechnology companies New investments include companies focused on Oncology,. ....